1 / 7

Sepsis Diagnostics Market Size & Analysis To 2026

The study segments the Sepsis Diagnostics industry in light of major classification such as product type, potential markets, application, and end-user.

Rugvedapatel
Download Presentation

Sepsis Diagnostics Market Size & Analysis To 2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Sepsis Diagnostics Market To Reach USD 772.1 Million By 2026

  2. Market Summary Increasing awareness across the globe, growing geriatric population, continuous growth in population, increasing environmental pollution and increased investments in the healthcare sector coupled with increased adoption of advanced technologies by the healthcare professionals key factors contributing to high CAGR of Sepsis Diagnostics during forecast period.Market Size – USD 385.0 Million in 2018, Market Growth - CAGR of 9%, Market Trends – Growing awareness and research in diagnosis of Sepsis.According to the current analysis of Reports and Data, the global Sepsis Diagnostics market was valued at USD 385.0 million in 2018 and is expected to reach USD 772.1 million by the year 2026, at a CAGR of 9.0%. Sepsis is one of the significant challenges faced by hospitals. Sepsis is a medical condition caused by an overactive immune response to an infection. The immune system releases chemicals for protecting the body from disease; however, excess of these chemicals causes other severe conditions, including inflammation, blood clots, and leaky blood vessels. The unsteady blood flow causes a lack of proper blood flow to all the body organs leading to organ failure and in extreme conditions, septic shock. Sepsis is most common in infants, pregnant women, sick people, and the old population. Thus, a rise in geriatric population has led to an increase in the sepsis diagnosis activities. www.reportsanddata.com

  3. Further key findings from the report suggest • Sepsis Diagnostics market is growing at a CAGR of 9% in Asia Pacific followed by North America and Europe with 8.7 % and 8.8% CAGR respectively. High prevalence of chronic diseases is expected to drive the market growth. • As of 2018, Blood Culture technology segment dominated Sepsis Diagnostics which holds 37.3% of the global market. North America regional market is the chief revenue generating source for this product segment, followed by Europe and Asia-Pacific regions. • The market of sepsis diagnostic is driven by the increase in sepsis cases, caused by gram-positive bacteria. The gram-positive bacterium has led to an increase in the number of patients with severe sepsis conditions and septic shock. • Introduction of new products for diagnostic purposes is expected to majorly drive the market for sepsis diagnosis in the coming years. For example, VIDAS B•R•A•H•M•S PCT, an automated assay measuring procalcitonin (PCT) levels launched by a leading in vitro diagnostic company, BioMérieux, enables the healthcare professions to take important decisions related to the recommendation of antibiotics for the patient.

  4. Market Summary Key Players: BioMérieux (France), Danaher (US), Becton, Dickinson and Company (US), Roche (Switzerland), and Abbott (US), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), CytoSorbents (US), and EKF (US) Segmentation: • For the purpose of this report, Reports and Data has segmented the Sepsis Diagnostics market on the basis of product type, technology type, pathogens type, method type, test type, end use, and region: • Product Type (Revenue, USD Million; 2016–2026) • Blood Culture Media • Assays & Reagents • Instruments • Software • Others To look at the PDF Sample Report and get 30 minutes of a free consultation @https://www.reportsanddata.com/sample-enquiry-form/2234 www.reportsanddata.com

  5. Market Summary • Technology Type (Revenue, USD Million; 2016–2026) • Microbiology • Molecular Diagnostics • Immunoassays • Flow Cytometry • Microfluidics • Biomarkers • Pathogens Type (Revenue, USD Million; 2016–2026) • Bacterial Sepsis • Gram-Positive Bacteria • Gram-Negative Bacteria • Fungal Sepsis • Others • MethodType (Revenue, USD Million; 2016–2026) • Conventional Diagnostic • Automatic Diagnostic Grab Your Report at an Impressive Discount! Please Click Here : https://www.reportsanddata.com/make-enquiry-form/2234 www.reportsanddata.com

  6. The report emphasizes the following key questions: Q.1.What are the most lucrative and promising growth prospects for the market? Q.2.Which sectors are expected to deliver a high growth rate and which industry aspects come into play in this advancement? Q.3.Which geographies are estimated to exhibit the highest growth and the underlying causes? Q.4.Which factors are impacting the future of the market and what are the driving factors? Q.5.What are the hurdles and challenges curtailing the industry’s growth in the forecast period? www.reportsanddata.com

  7. About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related